Terms of Service

Effective: June 11, 2026

1. Acceptance

By accessing or using Titrately ("the Service"), you agree to these Terms. If you are using the Service on behalf of a healthcare organization ("Host"), you represent that you have authority to bind that organization.

2. Service Description

Titrately is a clinical decision-support (CDS) module for ADHD medication titration. It provides:

• Structured between-visit patient telemetry capture.
• Titration timeline visualization with triage alerts.
• CYP2D6/CYP2C19 pharmacokinetic dosing reference cards sourced from CPIC guidelines.
• De-identified outcome data aggregation for research (with separate consent).

3. Not Medical Advice

Titrately is not a medical device and does not provide medical advice, diagnosis, or treatment recommendations. All outputs are reference materials and observational summaries. Clinical decisions are the sole responsibility of the licensed prescriber. The Service is designed to remain on the non-device CDS side of the FDA SaMD regulatory line.

4. Eligibility

The Service is intended for use by licensed healthcare professionals and their patients within a supervised clinical relationship. Host organizations must be healthcare entities capable of entering into Business Associate Agreements under HIPAA.

5. User Accounts

• Accounts are provisioned through host organizations or via SMART-on-FHIR launch.
• Users are responsible for maintaining the security of their credentials.
• Each user account is scoped to a single host organization.

6. Acceptable Use

You agree not to:

• Use the Service to auto-prescribe, auto-dose, or generate automated treatment recommendations.
• Bypass host-level data isolation or attempt to access another host's data.
• Reverse-engineer the PK dosing engine to create standalone prescribing tools.
• Use the Service in a manner that violates HIPAA, state privacy laws, or applicable regulations.
• Submit false or fabricated clinical data.

7. Data Ownership

• Clinical Data: Patient clinical data remains the property of the host organization and its patients.
• De-identified Research Data: Titrately retains rights to use consented, de-identified outcome data for the K4 data registry and research purposes.
• Platform IP: The PK dosing engine, triage algorithms, interface design, and software are proprietary to Titrately.

8. Host Integration

Host organizations are responsible for:

• Configuring SMART-on-FHIR/OAuth2 integration parameters.
• Obtaining appropriate patient consent before data flows into Titrately.
• Executing a Business Associate Agreement with Titrately.
• Ensuring their clinicians understand the non-prescriptive nature of the Service.

9. Limitation of Liability

To the maximum extent permitted by law, Titrately shall not be liable for any clinical decisions made using information from the Service. The Service surfaces reference materials and observational data; all prescribing decisions rest with the clinician.

10. Termination

Either party may terminate the service relationship with 30 days written notice. Upon termination, clinical data will be exported to the host organization and deleted from Titrately systems within 90 days, subject to audit log retention requirements.

11. Modifications

We may update these Terms with 30 days notice to host organizations. Continued use after the effective date constitutes acceptance.

12. Governing Law

These Terms are governed by the laws of the State of Delaware, United States.

13. Contact

For questions about these Terms: legal@titrately.com